These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 17027335)

  • 1. B-type natriuretic peptide levels predict event-free survival in patients with implantable cardioverter defibrillators.
    Christ M; Sharkova J; Bayrakcioglu S; Herzum I; Mueller C; Grimm W
    Eur J Heart Fail; 2007 Mar; 9(3):272-9. PubMed ID: 17027335
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Elevated B-type natriuretic peptide is associated with increased in-hospital mortality or cardiac arrest in patients undergoing implantable cardioverter-defibrillator implantation.
    Wei S; Loyo-Berríos NI; Haigney MC; Cheng H; Pinnow EE; Mitchell KR; Beachy JH; Woodward AM; Wang Y; Curtis JP; Marinac-Dabic D
    Circ Cardiovasc Qual Outcomes; 2011 May; 4(3):346-54. PubMed ID: 21487093
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Raised B-type natriuretic peptide predicts implantable cardioverter-defibrillator therapy in patients with ischaemic cardiomyopathy.
    Klingenberg R; Zugck C; Becker R; Schellberg D; Heinze G; Kell R; Remppis A; Schoels W; Katus HA; Dengler TJ
    Heart; 2006 Sep; 92(9):1323-4. PubMed ID: 16908708
    [No Abstract]   [Full Text] [Related]  

  • 4. Lower rather than higher levels of B-type natriuretic peptides (NT-pro-BNP and BNP) predict short-term mortality in end-stage heart failure patients treated with nesiritide.
    Miller WL; Burnett JC; Hartman KA; Henle MP; Burritt MF; Jaffe AS
    Am J Cardiol; 2005 Sep; 96(6):837-41. PubMed ID: 16169373
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Direct comparison between endothelin-1, N-terminal proatrial natriuretic factor, and brain natriuretic peptide as prognostic markers of survival in congestive heart failure.
    Selvais PL; Robert A; Ahn S; van Linden F; Ketelslegers JM; Pouleur H; Rousseau MF
    J Card Fail; 2000 Sep; 6(3):201-7. PubMed ID: 10997745
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Validation of the Seattle Heart Failure Model in a community-based heart failure population and enhancement by adding B-type natriuretic peptide.
    May HT; Horne BD; Levy WC; Kfoury AG; Rasmusson KD; Linker DT; Mozaffarian D; Anderson JL; Renlund DG
    Am J Cardiol; 2007 Aug; 100(4):697-700. PubMed ID: 17697831
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Preimplantation B-type natriuretic peptide concentration is an independent predictor of future appropriate implantable defibrillator therapies.
    Verma A; Kilicaslan F; Martin DO; Minor S; Starling R; Marrouche NF; Almahammed S; Wazni OM; Duggal S; Zuzek R; Yamaji H; Cummings J; Chung MK; Tchou PJ; Natale A
    Heart; 2006 Feb; 92(2):190-5. PubMed ID: 15923278
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increased N-terminal-pro-B-type natriuretic peptide levels in patients with appropriate implantable defibrillator therapies.
    Arnaldo FJ; Anatoliotakis N; Palacio C; Nabert DR; Hsu SS
    Heart Lung; 2009; 38(1):10-6. PubMed ID: 19150526
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Baseline and 6-month B-type natriuretic peptide changes are independent predictors of events in patients with advanced heart failure awaiting cardiac transplantation.
    Campana C; Pasotti M; Klersy C; Alessandrino G; Albertini R; Magrini G; Ghio S; Tavazzi L
    J Cardiovasc Med (Hagerstown); 2009 Sep; 10(9):671-6. PubMed ID: 19444135
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effectiveness of serial increases in amino-terminal pro-B-type natriuretic peptide levels to indicate the need for mechanical circulatory support in children with acute decompensated heart failure.
    Wong DT; George K; Wilson J; Manlhiot C; McCrindle BW; Adeli K; Kantor PF
    Am J Cardiol; 2011 Feb; 107(4):573-8. PubMed ID: 21295174
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of midregional pro-atrial natriuretic peptide with N-terminal pro-B-type natriuretic peptide in predicting survival in patients with chronic heart failure.
    von Haehling S; Jankowska EA; Morgenthaler NG; Vassanelli C; Zanolla L; Rozentryt P; Filippatos GS; Doehner W; Koehler F; Papassotiriou J; Kremastinos DT; Banasiak W; Struck J; Ponikowski P; Bergmann A; Anker SD
    J Am Coll Cardiol; 2007 Nov; 50(20):1973-80. PubMed ID: 17996563
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic value of apoptosis markers in advanced heart failure patients.
    Niessner A; Hohensinner PJ; Rychli K; Neuhold S; Zorn G; Richter B; Hülsmann M; Berger R; Mörtl D; Huber K; Wojta J; Pacher R
    Eur Heart J; 2009 Apr; 30(7):789-96. PubMed ID: 19196721
    [TBL] [Abstract][Full Text] [Related]  

  • 13. B-type natriuretic peptide: a role in selection and follow up of the implantable cardioverter-defibrillator patient?
    Anderson M
    Heart; 2006 Feb; 92(2):147-8. PubMed ID: 16415184
    [TBL] [Abstract][Full Text] [Related]  

  • 14. B-type natriuretic Peptide-guided treatment for predicting outcome in patients hospitalized in sub-intensive care unit with acute heart failure.
    Valle R; Aspromonte N; Giovinazzo P; Carbonieri E; Chiatto M; di Tano G; Feola M; Milli M; Fontebasso A; Barro S; Bardellotto S; Milani L
    J Card Fail; 2008 Apr; 14(3):219-24. PubMed ID: 18381185
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reduction in BNP levels with treatment of decompensated heart failure and future clinical events.
    Dhaliwal AS; Deswal A; Pritchett A; Aguilar D; Kar B; Souchek J; Bozkurt B
    J Card Fail; 2009 May; 15(4):293-9. PubMed ID: 19398076
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Primary results of the Rapid Emergency Department Heart Failure Outpatient Trial (REDHOT). A multicenter study of B-type natriuretic peptide levels, emergency department decision making, and outcomes in patients presenting with shortness of breath.
    Maisel A; Hollander JE; Guss D; McCullough P; Nowak R; Green G; Saltzberg M; Ellison SR; Bhalla MA; Bhalla V; Clopton P; Jesse R;
    J Am Coll Cardiol; 2004 Sep; 44(6):1328-33. PubMed ID: 15364340
    [TBL] [Abstract][Full Text] [Related]  

  • 17. B-type natriuretic peptide levels in obese patients with advanced heart failure.
    Horwich TB; Hamilton MA; Fonarow GC
    J Am Coll Cardiol; 2006 Jan; 47(1):85-90. PubMed ID: 16386669
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Combination of B-type natriuretic peptide and peak oxygen consumption improves risk stratification in outpatients with chronic heart failure.
    Isnard R; Pousset F; Chafirovskaïa O; Carayon A; Hulot JS; Thomas D; Komajda M
    Am Heart J; 2003 Oct; 146(4):729-35. PubMed ID: 14564330
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Biomarker-guided therapy in chronic heart failure: a meta-analysis of randomized controlled trials.
    Felker GM; Hasselblad V; Hernandez AF; O'Connor CM
    Am Heart J; 2009 Sep; 158(3):422-30. PubMed ID: 19699866
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interleukin-6 and tumor necrosis factor-alpha as biochemical markers of heart failure: a head-to-head clinical comparison with B-type natriuretic peptide.
    Boffa GM; Zaninotto M; Sartor R; Mion M; Berton A; Pasqualetto C; Razzolini R; Plebani M
    J Cardiovasc Med (Hagerstown); 2009 Oct; 10(10):758-64. PubMed ID: 19553828
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.